Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SIRPα and PD1 expression on tumor-associated macrophage predict prognosis of intrahepatic cholangiocarcinoma
Hui Yang, Meimei Yan, Wei Li, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Natural killer cells: a promising immunotherapy for cancer
Junfeng Chu, Fengcai Gao, Meimei Yan, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 114
The promising role of tumor-associated macrophages in the treatment of cancer
Hongbin Wang, Xueying Wang, Xin Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101041-101041
Closed Access | Times Cited: 58
Targeting macrophages: a novel treatment strategy in solid tumors
Mengmeng Liu, Lina Liu, Yongping Song, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 41
Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing
Wei Li, Binglei Zhang, Weijie Cao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Advanced insights on tumor-associated macrophages revealed by single-cell RNA sequencing: The intratumor heterogeneity, functional phenotypes, and cellular interactions
Sen Yang, Mengyi Wang, Yuze Hua, et al.
Cancer Letters (2024) Vol. 584, pp. 216610-216610
Closed Access | Times Cited: 11
A cuproptosis-related gene expression signature predicting clinical prognosis and immune responses in intrahepatic cholangiocarcinoma detected by single-cell RNA sequence analysis
Hefei Ren, Chang Liu, Cheng Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
From mechanism to therapy: the journey of CD24 in cancer
Kai Zhao, Caifeng Wu, Xiangjun Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma
Fei Chen, Jian Sheng, Xiaoping Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116659-116659
Open Access | Times Cited: 5
Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2V617F mutation
Wenjuan Fan, Weijie Cao, Jianxiang Shi, et al.
Annals of Hematology (2023) Vol. 102, Iss. 7, pp. 1745-1759
Open Access | Times Cited: 13
Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway
Huhu Zhang, Xiaolei Dong, Xiaoyan Ding, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Biochemical and biophysical mechanisms macrophages use to tune phagocytic appetite
Annalise Bond, Meghan A. Morrissey
Journal of Cell Science (2025) Vol. 138, Iss. 1
Closed Access
PPIH is a novel diagnostic biomarker associated with immune infiltration in cholangiocarcinoma
Jun Ye, Zhitao Chen, Chuan Zhang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Contribution of the p53/SERPINE1 Pathway to the Inflammatory Microenvironment and Senescent Phenotype in Cholangiocarcinoma
Ralf‐Peter Czekay, Paul J. Higgins
Inflammation (2025), pp. 1-20
Closed Access
Clinical Significance of Signal Regulatory Protein Alpha (SIRPα) Expression in Hepatocellular Carcinoma
Takahiro Tomiyama, Shinji Itoh, Norifumi Iseda, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 6, pp. 3378-3389
Closed Access | Times Cited: 8
Two birds with one stone: human SIRPα nanobodies for functional modulation and in vivo imaging of myeloid cells
Teresa R. Wagner, Simone Blaess, Inga B. Leske, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Immune cells in the B-cell lymphoma microenvironment: From basic research to clinical applications
Wenli Zhang, Mengmeng Liu, Wei Li, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 7, pp. 776-790
Open Access | Times Cited: 3
Igniting cold tumors of intrahepatic cholangiocarcinoma: An insight into immune evasion and tumor immune microenvironment
Xueyin Zhou, Bin Zhang, Jiahao Hu, et al.
The Innovation Medicine (2024) Vol. 2, Iss. 1, pp. 100052-100052
Open Access | Times Cited: 3
Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma
Linping Xu, Meimei Yan, Jianpeng Long, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Identification and prognostic analysis of ferroptosis‑related gene HSPA5 to predict the progression of lung squamous cell carcinoma
Di Guo, Yonghai Feng, Peijie Liu, et al.
Oncology Letters (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 2
Unlocking the future of hepatocellular carcinoma treatment: A comprehensive analysis of disulfidptosis-related lncRNAs for prognosis and drug screening
Haojun Wang, Wei Wang
Open Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma
Lotte Hoeijmakers, Irene L. M. Reijers, Christian U. Blank
Cancer Discovery (2023) Vol. 13, Iss. 11, pp. 2319-2338
Closed Access | Times Cited: 6
A New Serum Macrophage Checkpoint Biomarker for Innate Immunotherapy: Soluble Signal-Regulatory Protein Alpha (sSIRPα)
Yoanna V. Vladimirova, Marie K. Mølmer, Kristian W. Antonsen, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 937-937
Open Access | Times Cited: 9
Reprograming immune microenvironment modulates CD47 cancer stem cells in hepatocellular carcinoma
Eslam E. Abd El-Fattah, Hend Mostafa Selim
International Immunopharmacology (2022) Vol. 113, pp. 109475-109475
Closed Access | Times Cited: 8
Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis
Feng Xian, Dacheng Ren, Jun Bie, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
[Tumor-associated Macrophage: 
Emerging Targets for Modulating the Tumor Microenvironment].
Yinxue Zhou, Dunqiang Ren, Huanhuan Bi, et al.
PubMed (2024) Vol. 27, Iss. 3, pp. 231-240
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top